RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 109 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $19,000 | -80.2% | 3,374 | -66.0% | 0.00% | – |
| Q4 2021 | $96,000 | -49.2% | 9,935 | -6.2% | 0.00% | -100.0% |
| Q3 2021 | $189,000 | -26.5% | 10,593 | +0.5% | 0.00% | 0.0% |
| Q2 2021 | $257,000 | +38.9% | 10,537 | +50.9% | 0.00% | 0.0% |
| Q1 2021 | $185,000 | – | 6,982 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |